T1	Pharmacological_substance 20 31	enfuvirtide
N1000 	Reference T1 MeSH:C105196	enfuvirtide
T2	Pharmacological_substance 69 75	niacin
N1001 	Reference T2 MeSH:D009525	niacin
T3	Disorder 82 94	HIV-infected
N1 	Reference T3 UMLS:C0019693	HIV-infected
T4	Pharmacological_substance 156 167	enfuvirtide
N1002 	Reference T4 MeSH:C105196	enfuvirtide
T5	Pharmacological_substance 209 215	niacin
N1003 	Reference T5 MeSH:D009525	niacin
T7	Disorder 244 266	dilated cardiomyopathy
N2 	Reference T7 UMLS:C0007193	dilated cardiomyopathy
T8	Disorder 282 294	HIV-infected
N3 	Reference T8 UMLS:C0019693	HIV-infected
T9	Disorder 304 326	dilated cardiomyopathy
N4 	Reference T9 UMLS:C0007193	dilated cardiomyopathy
T10	Disorder 331 352	prolonged QT syndrome
N5 	Reference T10 UMLS:C0023976	prolonged QT syndrome
T11	Pharmacological_substance 447 458	enfuvirtide
N1004 	Reference T11 MeSH:C105196	enfuvirtide
T13	Pharmacological_substance 492 506	antiretroviral
T14	Pharmacological_substance 524 547	extended-release niacin
T18	Disorder 693 698	edema
N6 	Reference T18 UMLS:C0013604	edema
T19	Disorder 762 780	flushing sensation
N7 	Reference T19 UMLS:C0016382	flushing sensation
T20	Pharmacological_substance 788 794	niacin
N1005 	Reference T20 MeSH:D009525	niacin
T21	Pharmacological_substance 916 927	enfuvirtide
N1006 	Reference T21 MeSH:C105196	enfuvirtide
T22	Pharmacological_substance 961 967	niacin
N1007 	Reference T22 MeSH:D009525	niacin
T23	Pharmacological_substance 984 995	enfuvirtide
N1008 	Reference T23 MeSH:C105196	enfuvirtide
T24	Pharmacological_substance 1194 1206	enfurvirtide
N1009 	Reference T24 MeSH:C105196	enfurvirtide
T25	Pharmacological_substance 1211 1217	niacin
N1010 	Reference T25 MeSH:D009525	niacin
T26	Pharmacological_substance 1278 1289	enfuvirtide
N1011 	Reference T26 MeSH:C105196	enfuvirtide
T27	Pharmacological_substance 1294 1300	niacin
N1012 	Reference T27 MeSH:D009525	niacin
T28	Pharmacological_substance 1567 1578	enfuvirtide
N1013 	Reference T28 MeSH:C105196	enfuvirtide
T29	Pharmacological_substance 1612 1626	nicotinic acid
N1014 	Reference T29 MeSH:D009525	nicotinic acid
T30	Disorder 1688 1692	pain
N8 	Reference T30 UMLS:C0030193	pain
T31	Pharmacological_substance 1755 1764	cytokines
N1015 	Reference T31 MeSH:D016207	cytokines
T32	Pharmacological_substance 1884 1895	enfuvirtide
N1016 	Reference T32 MeSH:C105196	enfuvirtide
T33	Pharmacological_substance 1900 1906	niacin
N1017 	Reference T33 MeSH:D009525	niacin
T34	Disorder 1910 1922	HIV-infected
N9 	Reference T34 UMLS:C0019693	HIV-infected
T36	Pharmacological_substance 172 203	injectable HIV fusion inhibitor
T35	Pharmacological_substance 36 64	injectable fusion inhibitor,
T12	Subject 268 281;295 298	A 47-year-old man
T17	Disorder 1694 1701	redness
N10 	Reference T17 UMLS:C0041834	redness
T37	Disorder 1707 1715	swelling
N11 	Reference T37 UMLS:C0038999	swelling
T38	Subject 1923 1931	patients
T39	Coreferring_mention 649 656	patient
T41	Subject 95 102	patient
T44	Speculation_cue 116 125	potential
T45	Subject 219 221;235 238	an man
T6	Disorder 222 234	HIV-infected
N12 	Reference T6 UMLS:C0019693	HIV-infected
T47	Disorder 684 691	redness
N13 	Reference T47 UMLS:C0041834	redness
T48	Disorder 704 712	swelling
N14 	Reference T48 UMLS:C0038999	swelling
T51	Speculation_cue 1156 1164	probable
T55	Speculation_cue 1676 1679	may
T56	Pharmacological_substance 1770 1798	other inflammatory molecules
T57	Pharmacological_substance 1739 1753	Prostaglandins
N1018 	Reference T57 MeSH:D011453	Prostaglandins
T59	Speculation_cue 1848 1854	should
T60	Combination 1868 1883	coadministering
